Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3159)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,689
Price
$501.66
Total Value
$1.35M
Shares Held After
326,763
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,711
Price
$500.68
Total Value
$1.86M
Shares Held After
329,452
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$499.77
Total Value
$389.82K
Shares Held After
333,163
% of Holdings
0.2%
Ginkgo Bioworks Holdings, Inc. (DNA)
HENRY CHRISTIAN O — Director
Shares
5,000
Price
$7.08
Total Value
$35.41K
Shares Held After
19,310
% of Holdings
20.6%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
2,800
Price
$111.70
Total Value
$312.77K
Shares Held After
1,064,543
% of Holdings
0.3%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
400
Price
$110.84
Total Value
$44.33K
Shares Held After
1,067,343
% of Holdings
0.0%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
6,800
Price
$110.27
Total Value
$749.83K
Shares Held After
1,067,743
% of Holdings
0.6%
Phio Pharmaceuticals Corp. (PHIO)
BRADFORD PATRICIA A — Director
Shares
12,000
Price
$1.03
Total Value
$12.36K
Shares Held After
57,651
% of Holdings
20.8%
FENNEC PHARMACEUTICALS INC. (FENC)
Brughera Marco Maria — Director
Shares
15,545
Price
$10.29
Total Value
$159.96K
Shares Held After
0
% of Holdings
100.0%
Pharvaris N.V. (PHVS)
Souverijns Wim — Chief Commercial Officer
Shares
6,090
Price
$38.99
Total Value
$237.45K
Shares Held After
39,021
% of Holdings
13.5%
AIM ImmunoTech Inc. (AIM)
Equels Thomas K — Director
Shares
22,000
Price
$0.22
Total Value
$4.86K
Shares Held After
91,822
% of Holdings
24.0%
TENAX THERAPEUTICS, INC. (TENX)
Giordano Christopher Thomas — Director
Shares
4,850
Price
$1.82
Total Value
$8.84K
Shares Held After
22,174
% of Holdings
21.9%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
560
Price
$151.33
Total Value
$84.74K
Shares Held After
160,116
% of Holdings
0.3%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
263
Price
$150.40
Total Value
$39.56K
Shares Held After
160,676
% of Holdings
0.2%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
954
Price
$149.38
Total Value
$142.51K
Shares Held After
160,939
% of Holdings
0.6%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
35,000
Price
$3.30
Total Value
$115.39K
Shares Held After
3,183,000
% of Holdings
1.1%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
560
Price
$95.71
Total Value
$53.60K
Shares Held After
14,752
% of Holdings
3.7%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
2,452
Price
$95.71
Total Value
$234.68K
Shares Held After
923,128
% of Holdings
0.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
1,039
Price
$95.71
Total Value
$99.44K
Shares Held After
29,995
% of Holdings
3.3%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
947
Price
$95.71
Total Value
$90.64K
Shares Held After
31,771
% of Holdings
2.9%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
100
Price
$94.22
Total Value
$9.42K
Shares Held After
32,718
% of Holdings
0.3%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
1,366
Price
$92.99
Total Value
$127.02K
Shares Held After
32,818
% of Holdings
4.0%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
3,150
Price
$92.03
Total Value
$289.89K
Shares Held After
34,184
% of Holdings
8.4%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,384
Price
$91.10
Total Value
$217.17K
Shares Held After
37,334
% of Holdings
6.0%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
906
Price
$95.71
Total Value
$86.71K
Shares Held After
235,478
% of Holdings
0.4%
Ultragenyx Pharmaceutical Inc. (RARE)
Huizenga Theodore Alan — SVP, Chief Accounting Officer
Shares
1,283
Price
$13.57
Total Value
$17.41K
Shares Held After
67,863
% of Holdings
1.9%
Inhibrx Biosciences, Inc. (INBX)
MANHARD KIMBERLY — Director
Shares
500
Price
$105.05
Total Value
$52.52K
Shares Held After
7,500
% of Holdings
6.2%
CYTOKINETICS INC (CYTK)
Landry Robert E — Director
Shares
1,000
Price
$72.13
Total Value
$72.13K
Shares Held After
8,184
% of Holdings
10.9%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
97,926
Price
$69.33
Total Value
$6.79M
Shares Held After
0
% of Holdings
100.0%
PUMA BIOTECHNOLOGY, INC. (PBYI)
Cesano Alessandra — Director
Shares
62,150
Price
$9.12
Total Value
$566.99K
Shares Held After
56,700
% of Holdings
52.3%
PUMA BIOTECHNOLOGY, INC. (PBYI)
WILSON TROY EDWARD — Director
Shares
5,000
Price
$9.10
Total Value
$45.50K
Shares Held After
54,750
% of Holdings
8.4%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
28,505
Price
$1.29
Total Value
$36.88K
Shares Held After
829,505
% of Holdings
3.4%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
58,333
Price
$13.90
Total Value
$811.00K
Shares Held After
767,486
% of Holdings
7.1%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
40,294
Price
$144.13
Total Value
$5.81M
Shares Held After
1,525,858
% of Holdings
2.6%
VERACYTE, INC. (VCYT)
Holstein Jens — Director
Shares
5,000
Price
$40.95
Total Value
$204.75K
Shares Held After
27,471
% of Holdings
15.4%
CORCEPT THERAPEUTICS INC (CORT)
Lyon Joseph Douglas — Chief Accounting&Technology Officer
Shares
2,188
Price
$114.12
Total Value
$249.69K
Shares Held After
5,683
% of Holdings
27.8%
CORCEPT THERAPEUTICS INC (CORT)
Lyon Joseph Douglas — Chief Accounting&Technology Officer
Shares
7,812
Price
$113.32
Total Value
$885.26K
Shares Held After
7,871
% of Holdings
49.8%
YD Bio Ltd (YDES)
Shen Ethan PhD — Director
Shares
12,700
Price
$3.85
Total Value
$48.90K
Shares Held After
11,258,331
% of Holdings
0.1%
FRACTYL HEALTH, INC. (GUTS)
BRADLEY WILLIAM — Director
Shares
64,516
Price
$0.62
Total Value
$39.90K
Shares Held After
149,138
% of Holdings
43.3%
Pharvaris N.V. (PHVS)
Souverijns Wim — Chief Commercial Officer
Shares
20,000
Price
$39.31
Total Value
$786.13K
Shares Held After
45,111
% of Holdings
30.7%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
1,560
Price
$153.10
Total Value
$238.83K
Shares Held After
161,893
% of Holdings
1.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
6,160
Price
$152.12
Total Value
$937.03K
Shares Held After
163,453
% of Holdings
3.6%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
5,632
Price
$151.46
Total Value
$853.04K
Shares Held After
169,613
% of Holdings
3.2%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
GARNETT KEITHLY — CFO
Shares
257
Price
$3.89
Total Value
$1.00K
Shares Held After
242,357
% of Holdings
0.1%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
15,000
Price
$3.96
Total Value
$59.40K
Shares Held After
3,148,000
% of Holdings
0.5%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CHEN THOMAS C — Director
Shares
5,242
Price
$3.81
Total Value
$20.00K
Shares Held After
24,503
% of Holdings
21.4%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Chief Technology and Manufacturing Officer
Shares
2,587
Price
$1.93
Total Value
$4.99K
Shares Held After
509,198
% of Holdings
0.5%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance&Operations
Shares
1,658
Price
$1.93
Total Value
$3.20K
Shares Held After
502,907
% of Holdings
0.3%
Inhibrx Biosciences, Inc. (INBX)
MANHARD KIMBERLY — Director
Shares
500
Price
$110.26
Total Value
$55.13K
Shares Held After
8,000
% of Holdings
5.9%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$73.44
Total Value
$550.80K
Shares Held After
377,820
% of Holdings
1.9%
Showing 301–350 of 3159 transactions (page 7 of 64)